Target
Show/Hide Filters
Methyllycaconitine citrate (MLA) (HB2026)
Description:Potent, selective α7 nicotinic receptor antagonist
Purity:>95%
Mibefradil dihydrochloride (HB1226)
Description:Potent, reversible T- / L-type Ca2+ channel blocker
Purity:>95%
(+)-MK 801 maleate (HB0004)
Description:Potent, selective, non-competitive NMDA receptor antagonist
Purity:>98%
- Description:
Less active enantiomer of (+)-MK 801. NMDA receptor antagonist.
Purity:>99%